Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002959709 | SCV003672954 | uncertain significance | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.16756C>T (p.R5586W) alteration is located in exon 121 (coding exon 119) of the NEB gene. This alteration results from a C to T substitution at nucleotide position 16756, causing the arginine (R) at amino acid position 5586 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003135257 | SCV003813553 | uncertain significance | not provided | 2019-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003514603 | SCV004280500 | likely benign | Nemaline myopathy 2 | 2023-10-16 | criteria provided, single submitter | clinical testing |